Anti-IL-23 antibodies
First Claim
Patent Images
1. An isolated IL-23p19 antibody fragment, comprising a light chain variable region and a heavy chain variable region, said light chain variable region comprising:
- a complementarity determining region light chain 1 (CDRL1) amino acid sequence of SEQ ID NO;
39;
a CDRL2 amino acid sequence of SEQ ID NO;
40; and
a CDRL3 amino acid sequence of SEQ ID NO;
41,and said heavy chain variable region comprising;
a complementarity determining region heavy chain 1 (CDRH1) amino acid sequence of SEQ ID NO;
34;
a CDRH2 amino acid sequence of SEQ ID NO;
35; and
a CDRH3 amino acid sequence of SEQ ID NO;
36.
0 Assignments
0 Petitions
Accused Products
Abstract
An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
26 Citations
11 Claims
-
1. An isolated IL-23p19 antibody fragment, comprising a light chain variable region and a heavy chain variable region, said light chain variable region comprising:
-
a complementarity determining region light chain 1 (CDRL1) amino acid sequence of SEQ ID NO;
39;a CDRL2 amino acid sequence of SEQ ID NO;
40; anda CDRL3 amino acid sequence of SEQ ID NO;
41,and said heavy chain variable region comprising; a complementarity determining region heavy chain 1 (CDRH1) amino acid sequence of SEQ ID NO;
34;a CDRH2 amino acid sequence of SEQ ID NO;
35; anda CDRH3 amino acid sequence of SEQ ID NO;
36. - View Dependent Claims (2, 3, 5, 6, 7, 8, 9, 10, 11)
-
-
4. An isolated IL-23p19 antibody fragment, comprising a light chain variable region amino acid sequence of SEQ ID NO:
- 38 and a heavy chain variable region amino acid sequence of SEQ ID NO;
33.
- 38 and a heavy chain variable region amino acid sequence of SEQ ID NO;
Specification